A comprehensive view of european medicines agency (ema). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca's Evusheld antibody combination recommended for approval in the EU for pre-exposure prophylaxis of COVID-19; product is administered as two separate sequential intramuscular injections
Published: March 25, 2022 by AstraZeneca AB
Moderna announces European Medicines Agency has recommended a variation on conditional marketing authorization of Spikevax, the company's COVID-19 vaccine; vaccine now recommended for authorization in children aged six to 11
Published: February 24, 2022 by Moderna Inc.
European Medicines Agency approves additional manufacturing site for COVID-19 Vaccine Janssen in Marcy-l'Etoile, France, operated by Sanofi Pasteur
Published: December 17, 2021 by ENP Newswire
GSK and Vir Biotechnology announces marketing authorization in Europe for intravenous Xevudy as an early treatment for COVID-19 in patients at risk of progressing to severe illness
Published: December 17, 2021 by GlaxoSmithKline PLC
Merck announces European Commission approval of VAXNEUVANCE vaccine for prevention of invasive disease and pneumonia caused by Streptococcus pneumonia
Published: December 15, 2021 by Merck & Co. Inc.

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count